Skip to main content
. 2022 Dec 7;14(12):860. doi: 10.3390/toxins14120860

Figure 4.

Figure 4

Immunorecognition of N. nivea venom proteins by VAPAV. Panels illustrate the reverse-phase HPLC separation of the following into fractions: (A) whole venom proteins; (B) venom proteins immunoretained by the VAPAV-immobilized affinity column; (C) venom proteins that were not bound by the immunoaffinity column.